Cytokinetics (CYTK) Misses Q3 EPS by 13c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $76.10 +0.30%
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Research and development, grant and other revenues: 441K
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($1.36), $0.13 worse than the analyst estimate of ($1.23). Revenue for the quarter came in at $463 thousand versus the consensus estimate of $1.21 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
- Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance
- Evolution Petroleum to buy Midland Basin mineral rights for $16M
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
